[Relation between membrane potential changes and DNA, RNA and protein synthesis in regenerating liver cells after partial hepatectomy]. 1981

V V Frol'kis, and N M Turaeva, and Kh K Muradian, and E L Levitskiĭ

Variations in the membrane potential and in DNA, RNA and protein synthesis were studied in experiments on rats at varying times after hepatectomy. Hyperpolarization of the hepatocyte plasmatic membrane was shown to develop during liver regeneration along with activation of DNA, RNA and protein synthesis. Actinomycin D prevented the development of hyperpolarization and activation of RNA and protein synthesis. Administration of liver filtrates from hepatectomized rats to intact recipients induced hyperpolarization of liver cells. Activation of protein biosynthesis following hepatectomy resulted in hyperpolarization of the cell membrane, this action being mediated via formation of a specific membrane-active factor.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008110 Liver Extracts Extracts of liver tissue containing uncharacterized specific factors with specific activities; a soluble thermostable fraction of mammalian liver is used in the treatment of pernicious anemia. Perhepar,Extracts, Liver
D008115 Liver Regeneration Repair or renewal of hepatic tissue. Liver Regenerations,Regeneration, Liver,Regenerations, Liver
D008564 Membrane Potentials The voltage differences across a membrane. For cellular membranes they are computed by subtracting the voltage measured outside the membrane from the voltage measured inside the membrane. They result from differences of inside versus outside concentration of potassium, sodium, chloride, and other ions across cells' or ORGANELLES membranes. For excitable cells, the resting membrane potentials range between -30 and -100 millivolts. Physical, chemical, or electrical stimuli can make a membrane potential more negative (hyperpolarization), or less negative (depolarization). Resting Potentials,Transmembrane Potentials,Delta Psi,Resting Membrane Potential,Transmembrane Electrical Potential Difference,Transmembrane Potential Difference,Difference, Transmembrane Potential,Differences, Transmembrane Potential,Membrane Potential,Membrane Potential, Resting,Membrane Potentials, Resting,Potential Difference, Transmembrane,Potential Differences, Transmembrane,Potential, Membrane,Potential, Resting,Potential, Transmembrane,Potentials, Membrane,Potentials, Resting,Potentials, Transmembrane,Resting Membrane Potentials,Resting Potential,Transmembrane Potential,Transmembrane Potential Differences
D003609 Dactinomycin A compound composed of a two CYCLIC PEPTIDES attached to a phenoxazine that is derived from STREPTOMYCES parvullus. It binds to DNA and inhibits RNA synthesis (transcription), with chain elongation more sensitive than initiation, termination, or release. As a result of impaired mRNA production, protein synthesis also declines after dactinomycin therapy. (From AMA Drug Evaluations Annual, 1993, p2015) Actinomycin,Actinomycin D,Meractinomycin,Cosmegen,Cosmegen Lyovac,Lyovac-Cosmegen,Lyovac Cosmegen,Lyovac, Cosmegen,LyovacCosmegen
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D006498 Hepatectomy Excision of all or part of the liver. (Dorland, 28th ed) Hepatectomies
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012313 RNA A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode genetic information, serve as an abundant structural component of cells, and also possesses catalytic activity. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed) RNA, Non-Polyadenylated,Ribonucleic Acid,Gene Products, RNA,Non-Polyadenylated RNA,Acid, Ribonucleic,Non Polyadenylated RNA,RNA Gene Products,RNA, Non Polyadenylated
D014176 Protein Biosynthesis The biosynthesis of PEPTIDES and PROTEINS on RIBOSOMES, directed by MESSENGER RNA, via TRANSFER RNA that is charged with standard proteinogenic AMINO ACIDS. Genetic Translation,Peptide Biosynthesis, Ribosomal,Protein Translation,Translation, Genetic,Protein Biosynthesis, Ribosomal,Protein Synthesis, Ribosomal,Ribosomal Peptide Biosynthesis,mRNA Translation,Biosynthesis, Protein,Biosynthesis, Ribosomal Peptide,Biosynthesis, Ribosomal Protein,Genetic Translations,Ribosomal Protein Biosynthesis,Ribosomal Protein Synthesis,Synthesis, Ribosomal Protein,Translation, Protein,Translation, mRNA,mRNA Translations

Related Publications

V V Frol'kis, and N M Turaeva, and Kh K Muradian, and E L Levitskiĭ
December 1993, Nihon Geka Gakkai zasshi,
V V Frol'kis, and N M Turaeva, and Kh K Muradian, and E L Levitskiĭ
December 1996, Journal of gastroenterology and hepatology,
V V Frol'kis, and N M Turaeva, and Kh K Muradian, and E L Levitskiĭ
February 1967, Archives internationales de physiologie et de biochimie,
V V Frol'kis, and N M Turaeva, and Kh K Muradian, and E L Levitskiĭ
February 1965, Biochimica et biophysica acta,
V V Frol'kis, and N M Turaeva, and Kh K Muradian, and E L Levitskiĭ
April 1969, Cancer research,
V V Frol'kis, and N M Turaeva, and Kh K Muradian, and E L Levitskiĭ
December 1989, Biochemical Society transactions,
V V Frol'kis, and N M Turaeva, and Kh K Muradian, and E L Levitskiĭ
January 1968, Virchows Archiv. B, Cell pathology,
V V Frol'kis, and N M Turaeva, and Kh K Muradian, and E L Levitskiĭ
June 1965, Biochemical and biophysical research communications,
V V Frol'kis, and N M Turaeva, and Kh K Muradian, and E L Levitskiĭ
July 1969, Nutrition reviews,
V V Frol'kis, and N M Turaeva, and Kh K Muradian, and E L Levitskiĭ
March 1996, Hepatology (Baltimore, Md.),
Copied contents to your clipboard!